| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.04 |